Overview

Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of GW05 administered in 3 regimens versus metronidazole 0.75% for the treatment of bacterial vaginosis.
Phase:
Phase 2
Details
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Treatments:
Metronidazole